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Abstract
A 63-year-old male with history of prostate cancer treated with radiation presented for a colonoscopy for small 
volume hematochezia. The colonoscopy revealed numerous polyps, which were found to be ganglioneuromas 
on histological examination. He was referred to medical genetics with suspicion for hamartomatous polyposis 
syndrome and was found to have a mutation in the PTEN gene. Based on this and suggestive clinical findings, 
he was diagnosed with Bannayan Ruvalcaba Riley syndrome.
Introduction
Bannayan Ruvalcaba Riley syndrome (BRRS) is an autosomal dominant hamartomatous polyposis syndrome, 
findings of which can include intestinal polyposis in up to 45% of patients. Polyps are predominantly in the distal 
ileum and colon, but any part of the GI tract may be involved. BRRS is associated with a germline mutation of 
the tumor suppressor gene PTEN, although there does not appear to be an increased incidence of colorectal 
cancer or other gastrointestinal cancers in patients with BRRS. We report a patient found to have BRRS following 
diagnostic colonoscopy. 
Case Report
A 63-year-old Caucasian male presented for colonoscopy for evaluation of intermittent small volume hematochezia. 
He denied any abdominal or perianal pain, constipation, diarrhea, or weight loss. His past medical history was 
significant for a thyroidectomy 20 years ago for an unknown thyroid disorder and prostate cancer, which was 
diagnosed 3 years prior and treated with radiotherapy. At colonoscopy, he was noted to have multiple (>30) 1–10 
mm sessile polyps throughout the entire colon, all of which were resected via snare polypectomy except those in 
the sigmoid colon due to the duration of the procedure (Figure 1). He also had changes consistent with radiation 
proctopathy, thought to be the likely source of hematochezia, and was treated with argon plasma coagulation. 
Histopathologic examination of the colonic polyps showed evidence of spindle cell proliferation composed of 
Schwann cells expanding the lamina propria and distorting the overlying colonic crypts. Within the spindled 
stroma, numerous ganglion cells were identified (Figure 2), suggestive of mucosal ganglioneuromas.
Given the suspicion for a hamartomatous polyposis syndrome, he was referred to the genomic medicine ser-
vice. During this evaluation, the patient reported that his birth weight was over 10 pounds and he has always 
needed to wear extra-large hats. He also reported pigmented macules on his glans penis. There were no café-
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au-lait spots, inguinal or axillary freckling, or cutaneous neu-
rofibromas to suggest neurofibromatosis. His family history 
was significant for a 37-year-old son with learning delays and 
a 4-year-old grandson with concerns for muscle weakness 
and autism. Neither had undergone genetic evaluation. The 
patient had a 67% chance of having a PTEN mutation based 
on a clinical scoring system.1 Genetic testing demonstrated 
the presence of a pathogenic mutation (c.632dupG) on one 
copy of the PTEN gene. Based on clinical manifestations 
and the presence of the PTEN mutation, he was diagnosed 
with Bannayan Ruvalcaba Riley syndrome (BRRS). Genetic 
counseling of at-risk family members was also recommend-
ed. 
Discussion
BRRS is an autosomal dominant hamartomatous polyposis 
syndrome that encompasses 3 previously described disor-
ders including Riley-Smith syndrome, Bannayan-Zonana 
syndrome, and Ruvalcaba-Myhre-Smith syndrome. BRRS 
has an incidence of 1 in 200,000.2 Patients tend to be di-
agnosed early in life, and manifestations may include mac-
rocephaly, lipomatosis, hemangiomas, pigmented macules 
of the penis, high birth weight, proximal myopathy, joint hy-
perextensibility, pectus excavatum, and scoliosis, as well as 
developmental delay and intellectual deficiency.3 Intestinal 
polyposis is seen in up to 45% of patients predominantly in 
the distal ileum and colon, though any part of the GI tract 
can be involved.2 Thyroid pathology findings can be benign 
or malignant and include multinodular goiter, follicular ad-
enoma, or follicular and papillary carcinoma.4 BRRS is as-
sociated with germline mutations of the tumor suppressor 
gene PTEN, which has a significant role in the molecular 
pathway of cellular proliferation, migration, and apoptosis. 
Mutations in PTEN are seen in up to 65% of patients with a 
suspected diagnosis.5,6 If a mutation is confirmed, asymp-
tomatic, at-risk first and second degree relatives should be 
offered genetic counseling and testing if appropriate.
There are 3 other clinically distinct syndromes associated 
with PTEN mutations, collectively referred to as PTEN ham-
artoma tumor syndrome (PHTS). These allelic disorders in-
clude Cowden syndrome, Proteus syndrome, and Proteus-
like syndrome, and all have established diagnostic criteria.2,3 
The diagnosis of Cowden syndrome can be made using ei-
ther pathognomonic findings (facial trichilemmomas, acral 
keratosis, papillomatous papules, and mucosal lesions) or a 
combination of major criteria (breast cancer, thyroid cancer, 
macrocephaly, endometrial cancer, and Lhermitte-Duclos 
disease) and minor criteria (non-malignant thyroid lesions, 
mental retardation, hamartomatous intestinal polyps, fibro-
cystic breast disease, lipomas, fibromas, and genitourinary 
tumors or malformations). Diagnostic criteria for Proteus syn-
drome include malformations and hamartomatous over-
growths of multiple tissue, connective tissue nevi, and epi-
dermal nevi, while tumors including ovarian cystadenoma, 
testicular tumors, central nervous system tumors, and pa-
rotid adenomas have been observed in a subset of patients. 
Patients with features of Proteus syndrome but not meet-
ing diagnostic criteria are given the diagnosis of Proteus-like 
syndrome.  
No such criteria exist for BRRS, but the syndrome is sus-
pected in the presence of macrocephaly, hamartomatous 
intestinal polyposis, and pigmented macules of the glans 
penis in males, all of which were present in our patient. In 
addition, he had a presumably associated benign thyroid 
manifestation. In the absence of definitive diagnostic criteria 
for BRRS, a scoring system has been developed to assess 
the likelihood of a PTEN mutation based on the constella-
tion of clinical findings in a patient suspected of having the 
condition.1 It should be noted that some authorities feel that 
Figure 1. Endoscopic photograph of colonic polyps.
Figure 2. (A) Photomicrograph of resected polyp showing a large gan-
glioneuroma. (B) Immunohistochemical stain with S-100 highlighting the 
Schwann cells and sparing the ganglion cells.
A B
Publish your work in ACG Case Reports Journal
ACG Case Reports Journal is a peer-reviewed, open-access publication that provides GI fellows, private practice clinicians, and other members of the 
health care team an opportunity to share interesting case reports with their peers and with leaders in the field. Visit http://acgcasereports.gi.org for 
submission guidelines. Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.
Sagi et al
acgcasereports.gi.org
Bannayan Ruvalcaba Riley Syndrome
92 ACG Case Reports Journal | Volume 1 | Issue 2 | January 2014
Cowden syndrome and BRRS are varying spectrums of the 
same syndrome, while others feel that these are distinct enti-
ties.2,6 
There has been no reported increased incidence of colorec-
tal cancer or other gastrointestinal cancers in patients with 
BRRS to date, though this is a rare condition with few data 
from large patient cohorts.7 Patients with BRRS should un-
dergo screening and surveillance for gastrointestinal ma-
lignancies, including colorectal cancer, as per guidelines 
for average risk patients. Polyps without malignant poten-
tial (such as our patient’s ganglioneuromas) do not require 
heightened surveillance. Patients with BRRS and PTEN 
mutations may have an undefined increased extra-intestinal 
cancer risk, and it has been suggested they follow the same 
surveillance recommendations as patients with Cowden syn-
drome, with screening for breast cancer, thyroid cancer, and 
uterine cancer.2,3
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